Cargando…
Innate Immune Cells in Pressure Overload-Induced Cardiac Hypertrophy and Remodeling
Pressure overload and heart failure are among the leading causes of cardiovascular morbidity and mortality. Accumulating evidence suggests that inflammatory cell activation and release of inflammatory mediators are of vital importance during the pathogenesis of these cardiac diseases. Yet, the roles...
Autores principales: | Liu, Xin, Shi, Guo-Ping, Guo, Junli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343105/ https://www.ncbi.nlm.nih.gov/pubmed/34368120 http://dx.doi.org/10.3389/fcell.2021.659666 |
Ejemplares similares
-
SOCS3 Negatively Regulates Cardiac Hypertrophy via Targeting GRP78-Mediated ER Stress During Pressure Overload
por: Liu, Shuang, et al.
Publicado: (2021) -
Activation of transient receptor potential vanilloid 4 is involved in pressure overload-induced cardiac hypertrophy
por: Zou, Yan, et al.
Publicado: (2022) -
The Ca(2+)-activated cation channel TRPM4 is a positive regulator of pressure overload-induced cardiac hypertrophy
por: Guo, Yang, et al.
Publicado: (2021) -
Neonatal Heart Responds to Pressure Overload With Differential Alterations in Various Cardiomyocyte Maturation Programs That Accommodate Simultaneous Hypertrophy and Hyperplasia
por: Ding, Xiaoning, et al.
Publicado: (2020) -
Comprehensive Expression Analysis of Cardiac Fibroblast Growth Factor 23 in Health and Pressure-induced Cardiac Hypertrophy
por: Eitner, Fiona, et al.
Publicado: (2022)